NASDAQ:KTTA

Pasithea Therapeutics Stock Forecast

etoro logo Buy KTTA
*Your capital is at risk
$0.730
+0.0122 (+1.70%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of KTTA
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Green day on Monday for Pasithea Therapeutics Corp. stock after gaining 1.70%
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Nov 11, 2025 Gain 2.83%

The Pasithea Therapeutics Corp. stock price gained 1.70% on the last trading day (Monday, 17th Nov 2025), rising from $0.718 to $0.730. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.49% from a day low at $0.710 to a day high of $0.749. The price has been going up and down for this period, and there has been a -10.52% loss for the last 2 weeks. Volume fell on the last day by -80 thousand shares and in total, 33 thousand shares were bought and sold for approximately $23.92 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.31% during the next 3 months and, with a 90% probability hold a price between $0.664 and $0.84 at the end of this 3-month period.

KTTA Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, November 07, 2025, and so far it has risen 5.81%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pasithea Therapeutics Corp. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.749. On a fall, the stock will find some support from the short-term average at $0.712. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Pasithea Therapeutics Corp. stock

Pasithea Therapeutics Corp. finds support from accumulated volume at $0.730 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0390 between high and low, or 5.49%. For the last week the stock has had daily average volatility of 6.08%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KTTA) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Pasithea Therapeutics Corp. to open at $0.730, and during the day (based on 14 day Average True Range), to move between $0.704 and $0.756, which gives a possible trading interval of +/-$0.0516 (+/-7.32%) up or down from last closing price. If Pasithea Therapeutics Corp. takes out the full calculated possible swing range there will be an estimated 7.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.730 (0.07%) than the resistance at $0.744 (1.93%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Pasithea Therapeutics Corp. stock A Buy?

Pasithea Therapeutics Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.076 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.730 ( 0.0548%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

KTTA Performance

Trading levels for KTTA

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.769 5.29%
R2 0.754 3.25%
R1 0.745 1.99%
Price 0.730
S1 0.715 -2.10%
S2 0.706 -3.36%
S3 0.691 -5.40%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.90 23.09%
R2 0.84 15.20%
R1 0.744 1.93%
Price 0.730
S1 0.730 -0.0685%
S2 0.723 -1.00%
S3 0.718 -1.67%

FAQ

What is the symbol for Pasithea Therapeutics Corp. Stock and on which exchange is it traded?
The symbol for Pasithea Therapeutics Corp. is KTTA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pasithea Therapeutics Corp. Stock?
Pasithea Therapeutics Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Pasithea Therapeutics Corp. Stock?
Pasithea Therapeutics Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pasithea Therapeutics Corp. Stock.

What's the current price of Pasithea Therapeutics Corp. Stock?
As of the end of day on the Nov 17, 2025, the price of an Pasithea Therapeutics Corp. (KTTA) share was $0.730.

What is the 52-week high and low for Pasithea Therapeutics Corp. Stock?
The 52-week high for Pasithea Therapeutics Corp. Stock is $3.85 and the 52-week low is $0.650.

What is the market capitalization of Pasithea Therapeutics Corp. Stock?
As of the Nov 17, 2025, the market capitalization of Pasithea Therapeutics Corp. is 5.435M.

When is the next earnings date for Pasithea Therapeutics Corp.?
The upcoming earnings date for Pasithea Therapeutics Corp. is Mar 23, 2026.
Click to get the best stock tips daily for free!
ABOUT PASITHEA THERAPEUTICS CORP.
Pasithea Therapeutics
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida....
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE